Selected article for: "immune response and important sequence"

Author: Barzon, Luisa; Lavezzo, Enrico; Militello, Valentina; Toppo, Stefano; Palù, Giorgio
Title: Applications of Next-Generation Sequencing Technologies to Diagnostic Virology
  • Document date: 2011_11_14
  • ID: 01nuj0lk_32
    Snippet: High mutation rates inherent to replication of RNA viruses create a wide variety of mutants that are present in virus populations, which are often referred to as quasispecies [80] . The diffuse, "cloud-like" nature of viral populations allows them to rapidly adapt to changing replicative environments by selecting preexisting variants with better fitness [81, 82] . Thus, many important virus properties cannot be explained by a mere consensus seque.....
    Document: High mutation rates inherent to replication of RNA viruses create a wide variety of mutants that are present in virus populations, which are often referred to as quasispecies [80] . The diffuse, "cloud-like" nature of viral populations allows them to rapidly adapt to changing replicative environments by selecting preexisting variants with better fitness [81, 82] . Thus, many important virus properties cannot be explained by a mere consensus sequence, but require knowledge about the microvariants present in viral populations. These sequence variants may be critically relevant to viral evolution and spread, virulence, evasion of the immune response, anti-viral drug resistance, and vaccine development and manufacture.

    Search related documents:
    Co phrase search for related documents
    • anti viral drug resistance and immune response: 1
    • anti viral drug resistance and RNA virus: 1
    • anti viral drug resistance and vaccine development: 1
    • consensus sequence and drug resistance: 1, 2, 3
    • consensus sequence and high mutation: 1, 2, 3, 4, 5, 6
    • consensus sequence and high mutation rate: 1, 2
    • consensus sequence and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • consensus sequence and RNA virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • consensus sequence and RNA virus replication: 1
    • consensus sequence and sequence variant: 1, 2, 3, 4, 5
    • consensus sequence and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • consensus sequence and viral evolution: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • drug resistance and high mutation rate: 1, 2, 3, 4, 5, 6, 7, 8
    • drug resistance and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • drug resistance and RNA virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • drug resistance and RNA virus replication: 1
    • drug resistance and sequence variant: 1
    • drug resistance and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • drug resistance and viral evolution: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20